Medline Inc. (MDLN)

NASDAQ: MDLN · Real-Time Price · USD

42.16

+1.25 (3.06%)

At close: Nov 11, 2026, 4:00 PM EST

43.00

+0.84 (1.99%)

Pre-market: Nov 12, 2026, 7:58 AM EST

Medline Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	30,680	28,432	25,507	23,231	21,448
Revenue Growth	11.85%	11.47%	9.80%	8.31%	-
Gross Profit	7,493	7,518	6,976	5,885	5,217
Operating Income	1,666	2,179	2,148	1,411	861
Net Income	573	1,159	1,200	234	-25
Earnings Per Share	0.65	1.43	0.07	0.01	-
EPS Growth	800.07%	1982.77%	413.80%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Front Line Care	6,738	6,514	6,088	5,845	5,709
Surgical Solutions	6,525	6,166	5,471	4,931	4,446
Laboratory and Diagnostics	1,102	1,040	956	837	844
Supply Chain Solutions	16,315	14,712	12,992	11,618	10,449
Revenue (Total)	30,680	28,432	25,507	23,231	21,448

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	3,621	1,975	278	1,691	-
Total Debt	12,648	13,013	16,899	16,832	-
Net Cash (Debt)	-9,027	-11,038	-16,621	-15,141	-
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-10.27	-13.63	-0.95	-0.87	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	2,381	1,744	1,769	1,685	187
Capital Expenditures	-501	-480	-364	-285	-254
Free Cash Flow	1,880	1,264	1,405	1,400	-67
Free Cash Flow Growth	86.32%	-10.04%	0.36%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	24.42%	26.44%	27.35%	25.33%	24.32%
Operating Margin	5.43%	7.66%	8.42%	6.07%	4.01%
Pretax Margin	3.64%	4.39%	4.88%	1.14%	0.05%
Profit Margin	1.87%	4.08%	4.71%	1.01%	-0.12%
FCF Margin	6.13%	4.45%	5.51%	6.03%	-0.31%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	64.67	30.16	-	-	-
P/FCF Ratio	29.50	27.65	-	-	-
PS Ratio	1.81	1.23	-	-	-